| | December 20196CIOReviewGone are the days when people used to visit hospitals only when they fell ill. Today's proactive, digitally sound, and well-informed patients demand more advanced care. Keeping pace with this ever-evolving patient demand, the pharmaceutical and life sciences industry is moving toward a preventive model by utilizing patient information and applying advanced data analytics. They are synthesizing historical, internal, and external data to empower R&D organizations to bolster early research, identify unmet medical requirements, and have a competitive edge in the long bringing in advanced devices as well as drugs. Subsequently, the world is going to witness an exponential leap of the global healthcare data in the coming years. According to Statista, almost 2,314 exabytes of new data will be generated by 2020. However, due to this constant endeavor to be digitally fit and urge to introduce a diverse range of products, several complexities have emerged before the players of the pharma and life sciences industry. The first one is the regulatory requirements. Take the Food and Drug Administration (FDA), for instance, which is on a mission to protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs and biological products. In effect, having a proper understanding of the ever-changing regulations is imperative. Additionally, the failure to have the right information at the right time often hinders pharma and life sciences companies' operational efficiencies. Hopefully, fathoming the gravity of the situation, life sciences companies across the globe are making considerable investments and establishing a partnership with innovative information technology companies. It can be expected that in the upcoming days, all these problems will be solved, and patients will be served with more efficiency. The sole aim of this edition is to provide readers with the knowledge of the best-in-breed service models, solutions, and insights from industry leaders to help them have a detailed understanding of the pharma and life sciences tech arena and the recent developments in this field.Let us know your thoughts.EditorialA Journey toward a Better FutureCopyright © 2019 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.CIOReviewContact Us:Phone:510-230-0395Fax:510-894-8405Email:sales@cioreview.comeditor@cioreview.commarketing@cioreview.com December - 20, 2019, Vol 08, Issue - 134 (ISSN 2644-237X) Published by ValleyMedia, Inc.To subscribe to CIOReviewVisit www.cioreview.com CIOReviewEditorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersIssac GeorgeBrian Harding*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffJustin Smith Managing Editoreditor@cioreview.comManaging EditorJustin SmithSalesStephen Thomasstephen.thomas@cioreview.com Dean Winchester
<
Page 5 |
Page 7 >